| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |